HCV NS3 recombinant antigens and mutants thereof for improved antibody detection

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9790478
APP PUB NO 20140272932A1
SERIAL NO

14139053

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to polypeptides, including fusions thereof, nucleic acids, vectors, host cells, immunodiagnostic reagents, kits, and immunoassays for use detecting the presence of HCV antibodies. More specifically, the present invention describes specific NS3 antigens that can be used for the detection of anti-HCV antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBOTT LABORATORIES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Birkenmeyer, Larry Glenview, US 6 87
Bogdan, M Felisha Gurnee, US 1 2
Gutierrez, Robin Gurnee, US 2 17
Marohnic, Christopher Kenosha, US 10 44
Muerhoff, A Scott Kenosha, US 21 158
Prostko, John Kenosha, US 6 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 17, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 17, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00